← 홈

림프종

650개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 650개
CGTBiologicstaleAutolus LimitedPhase 2

CAR-T cells targeting CD19 and CD22 (CAR-T cells targeting CD19 and CD22)

B-Cell Acute Lymphoblastic Leukemia, Adult · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 1%임상시험 2상태 RECRUITING
CGTBiologicstaleThe Beijing Pregene Science and…Phase 2

CART-19 cells (CART-19 cells)

B-cell Acute Lymphoblastic Leukemia · B-cell Acute Lymphoblastic Leukemia

#B-cellAcuteLymphoblasticLeukemia#CGT#Phase2#세포유전치료#CAR-T+2
효능 ORR 43.8%임상시험 2상태 ACTIVE
CGTBiologicstaleTimmune Biotech Inc.Phase 1

CD19-TriCAR-T/SILK (CD19-TriCAR-T/SILK)

Non-Hodgkin Lymphoma of Intestine; Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 2상태 ACTIVE
CGTBiologicstaleShanghai Ming Ju Biotechnology …Phase 2

CD19-targeted Chimeric Antigen Receptor (CAR, CD19-targeted Chimeric Antigen Receptor, CD19-targeted Chimeric Antigen Receptor (CAR) T Cells)

Lymphoma, Non-Hodgkin; Diffuse Large B Cell Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+5
효능 ORR 94%임상시험 2상태 ACTIVE
CGTBiologicstaleOneChain ImmunotherapeuticsPhase 1

CD1a-CAR T (CD1a-CAR T)

T-cell Acute Lymphoblastic Leukemia; Lymphoblastic T-Cell Lymphoma · T-cell Acute Lymphoblastic Leukemia

#T-cellAcuteLymphoblasticLeukemia#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 2상태 RECRUITING
CGTBiologicstaleBaylor College of MedicinePhase 1

CD30.CAR-EBVST cells (CD30.CAR-EBVST cells)

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type; Classical Hodgkin Lymphoma · CD30

#CD30#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 2상태 DISCONTINUED
AntibodystaleRochePreclinical

CHOP+RITUXIMAB (CHOP+RITUXIMAB)

Non-Hodgkins Lymphoma · Lymphoma, Large-Cell, Diffuse

#LymphomaLarge-CellDiffuse#Antibody#Preclinical#항체#면역항체+3
임상시험 2상태 ACTIVE
ADCBiologicstaleLymphoma Study AssociationPhase 3

Carboplatine (Carboplatine)

Lymphoma, Large-Cell, Diffuse · Hodgkin Disease

#HodgkinDisease#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 ACTIVE
CGTBiologicstaleCartesian TherapeuticsPhase 2

CAR-T (Chimeric Antigen Receptor T Cells, Chimeric Antigen Receptor T Cells (CAR-T))

Relapsed or Refractory Aggressive B-cell Lymphoma · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 67%임상시험 2상태 RECRUITING
CGTBiologicstaleNanjing Legend Biotech Co.Phase 2

Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy (Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy)

Lymphoma, B-Cell · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 2상태 ACTIVE
ADCBiologicstaleSeagenPhase 2

brentuximab vedotin (Adcetris, Induction without Brentuximab Vedotin)

Hodgkin Lymphoma, Adult · Hodgkin Lymphoma, Adult

#HodgkinLymphomaAdult#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 2상태 RECRUITING
CGTBiologicstaleJuno Therapeutics, a Subsidiary…Phase 2

JCARH125 (JCARH125)

Non Hodgkin Lymphoma; Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 42.9%임상시험 2상태 ACTIVE
ADCBiologicstaleMenarini GroupPhase 1

MEN1309 (MEN1309)

Metastatic Solid Tumors; Relapsed/Refractory Non-Hodgkin Lymphoma · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4
임상시험 2상태 DISCONTINUED
ADCBiologicstaleGenentech, Inc.Phase 2

Pinatuzumab Vedotin (Pinatuzumab Vedotin)

Follicular Lymphoma; Diffuse Large B-Cell Lymphoma · Follicular Lymphoma

#FollicularLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 6.24%임상시험 2상태 ACTIVE
CGTBiologicstaleNektar TherapeuticsPhase 1

Polymer-conjugated IL-15 Receptor Agonist NKTR-255 (Polymer-conjugated IL-15 Receptor Agonist NKTR-255)

Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 2상태 RECRUITING
AntibodystaleRochePhase 2

Rituximab/Gemcitabine/Oxaliplatin (Rituximab/Gemcitabine/Oxaliplatin)

Refractory Aggressive Non-Hodgkin's Lymphoma; Relapsing Aggressive Non-Hodgkin's Lymphoma · Combination Therapy

#CombinationTherapy#Antibody#Phase2#항체#면역항체+4
효능 ORR 69.7%임상시험 2상태 RECRUITING
CGTBiologicSana BiotechnologyPhase 1

SC291 (SC291)

Non Hodgkin Lymphoma; Chronic Lymphocytic Leukemia · Lupus Erythematosus

#LupusErythematosus#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 2상태 RECRUITING
CGTBiologicstaleWugen, Inc.Phase 2

WU-CART-007 (WU-CART-007)

T-cell Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma · T-cell Acute Lymphoblastic Leukemia

#T-cellAcuteLymphoblasticLeukemia#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 2상태 ACTIVE
CGTBiologicstaleKite, A Gilead CompanyPhase 1

anti-CD19 CAR-T (anti-CD19 CAR-T)

B-cell Adult Acute Lymphoblastic Leukemia; B-cell Chronic Lymphocytic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 94%임상시험 2상태 ACTIVE
CGTBiologicstaleCity of Hope Medical CenterPhase 1

autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells (autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells)

Adult Grade III Lymphomatoid Granulomatosis; Cutaneous B-cell Non-Hodgkin Lymphoma · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 2상태 RECRUITING

13 / 33 페이지

← 이전다음 →